SAN FRANCISCO, October 3, 2017 /PRNewswire/ --
The global wearable injectors market is anticipated to reach USD 11.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring. The paradigm shift towards self-administration of injectable is expected to drive the market during the forecast period. In addition, increasing awareness and rising adoption of wearable injectors are expected to assist in growth.
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )
Technological advancements in wearable injectors, such as Bluetooth integrated wearable injectors, enable sending alerts to patients, such as injection reminders, and provide patients access to data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and others prevent accidental activation. They also have audio and visual status indicators or signals. Patients can self-administer drugs subcutaneously in less time and with minimal effort as compared to intravenous or other routes. Patients are not required to visit any healthcare provider for administration.
Prevalence of lifestyle-associated diseases, such as diabetes and hypertension, is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access with minimal errors, is expected to boost the wearable injectors market.
Browse full research report with TOC on "Wearable Injectors Market Analysis By Type (On-body, Off-body), Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery), By Application (Oncology, Autoimmune Disease), By End-Use, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/wearable-injectors-market
Further Key Findings From the Report Suggest:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
Web: http://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
Advertisement
The global wearable injectors market is anticipated to reach USD 11.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring. The paradigm shift towards self-administration of injectable is expected to drive the market during the forecast period. In addition, increasing awareness and rising adoption of wearable injectors are expected to assist in growth.
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )
Technological advancements in wearable injectors, such as Bluetooth integrated wearable injectors, enable sending alerts to patients, such as injection reminders, and provide patients access to data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and others prevent accidental activation. They also have audio and visual status indicators or signals. Patients can self-administer drugs subcutaneously in less time and with minimal effort as compared to intravenous or other routes. Patients are not required to visit any healthcare provider for administration.
Prevalence of lifestyle-associated diseases, such as diabetes and hypertension, is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access with minimal errors, is expected to boost the wearable injectors market.
Browse full research report with TOC on "Wearable Injectors Market Analysis By Type (On-body, Off-body), Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery), By Application (Oncology, Autoimmune Disease), By End-Use, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/wearable-injectors-market
Further Key Findings From the Report Suggest:
- The on-body segment held lucrative market share in 2016, owing to growing preference of patients for adhesive patches that release the drug easily and can be worn on the skin
- The motor-driven segment is expected to register the highest growth over the forecast period owing to increasing demand from hospitals, clinics, retail chain stores, and pharmacies
- The oncology segment is expected to gain the largest market share due to increasing incidence of cancer worldwide
- North America is expected to dominate the wearable injectors market over the forecast period due to rising demand for innovative Information Technology (IT) solutions to streamline workflow and increasing regulatory requirements to ensure patient safety
- Some of the key players in wearable injectors market are Becton, Dickinson and Company; Johnson & Johnson Services, Inc.; F. Hoffmann-La Roche Ltd.; Unilife Corporation; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet Corporation; Enable Injections; West Pharmaceutical Services, Inc.; and CeQur SA.
- Contrast Media/Contrast Agents Market - http://www.grandviewresearch.com/industry-analysis/contrast-media-contrast-agents-market
- Hospital Microbiology Testing Market - http://www.grandviewresearch.com/industry-analysis/hospital-microbiology-testing-market
- Extracorporeal Shock Wave Lithotripsy Market - http://www.grandviewresearch.com/industry-analysis/extracorporeal-shock-wave-lithotripsy-market
- Catheter Stabilization Device Market - http://www.grandviewresearch.com/industry-analysis/catheter-stabilization-device-market
- Type Outlook (Revenue, USD Million, 2014 - 2025)
- On-body
- Off-body
- Technology Outlook (Revenue, USD Million, 2014 - 2025)
- Spring-based
- Motor-driven
- Rotary Pump
- Expanding Battery
- Other
- Application Outlook (Revenue, USD Million, 2014 - 2025)
- Oncology
- Infectious Disease
- Cardiovascular Disease
- Autoimmune Disease
- Other
- End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospital
- Clinic
- Home Care
- Other
- Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East and Africa (MEA)
- South Africa
- North America
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
Web: http://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
